These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
13. On the value of measuring CSF hypocretin-1 in diagnosing narcolepsy. Mignot E; Chen W; Black J Sleep; 2003 Sep; 26(6):646-9. PubMed ID: 14572113 [No Abstract] [Full Text] [Related]
14. Hypocretin (orexin) deficiency in narcolepsy and primary hypersomnia. Ebrahim IO; Sharief MK; de Lacy S; Semra YK; Howard RS; Kopelman MD; Williams AJ J Neurol Neurosurg Psychiatry; 2003 Jan; 74(1):127-30. PubMed ID: 12486284 [TBL] [Abstract][Full Text] [Related]
15. Narcolepsy without cataplexy: 2 subtypes based on CSF hypocretin-1/orexin-A findings. Oka Y; Inoue Y; Kanbayashi T; Kuroda K; Miyamoto M; Miyamoto T; Ikeda A; Shimizu T; Hishikawa Y; Shibasaki H Sleep; 2006 Nov; 29(11):1439-43. PubMed ID: 17162990 [TBL] [Abstract][Full Text] [Related]
16. The level of hypocretin 1 (orexin A) in cerebrospinal fluid and the diagnosis of narcolepsy and other somnolent disorders. Kunimoto M Intern Med; 2003 Aug; 42(8):634-5. PubMed ID: 12924483 [No Abstract] [Full Text] [Related]
17. Hypocretin-1 (orexin-A) levels in human lumbar CSF in different age groups: infants to elderly persons. Kanbayashi T; Yano T; Ishiguro H; Kawanishi K; Chiba S; Aizawa R; Sawaishi Y; Hirota K; Nishino S; Shimizu T Sleep; 2002 May; 25(3):337-9. PubMed ID: 12003164 [TBL] [Abstract][Full Text] [Related]
18. Screening for anti-ganglioside antibodies in hypocretin-deficient human narcolepsy. Overeem S; Geleijns K; Garssen MP; Jacobs BC; van Doorn PA; Lammers GJ Neurosci Lett; 2003 Apr; 341(1):13-6. PubMed ID: 12676332 [TBL] [Abstract][Full Text] [Related]
19. CSF hypocretin-1 levels in narcolepsy, Kleine-Levin syndrome, and other hypersomnias and neurological conditions. Dauvilliers Y; Baumann CR; Carlander B; Bischof M; Blatter T; Lecendreux M; Maly F; Besset A; Touchon J; Billiard M; Tafti M; Bassetti CL J Neurol Neurosurg Psychiatry; 2003 Dec; 74(12):1667-73. PubMed ID: 14638887 [TBL] [Abstract][Full Text] [Related]
20. Developmental changes in CSF hypocretin-1 (orexin-A) levels in normal and genetically narcoleptic Doberman pinschers. John J; Wu MF; Maidment NT; Lam HA; Boehmer LN; Patton M; Siegel JM J Physiol; 2004 Oct; 560(Pt 2):587-92. PubMed ID: 15308685 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]